Supernus Pharmaceuticals
SUPN
$30.07
Share price
2.59%
Change (1 day)
-18.42%
Change (1 year)
Categories
Supernus Pharmaceuticals (SUPN) - Net assets
Net assets on the balance sheet as of December 2023 : $0.92 B
According to Supernus Pharmaceuticals
's latest financial reports the company has $0.92 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Supernus Pharmaceuticals - Net assets on balance sheet (from 2009 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.92 B | 3.98% |
| 2022-12-31 | $0.88 B | 8.62% |
| 2021-12-31 | $0.81 B | 9.53% |
| 2020-12-31 | $0.74 B | 25.1% |
| 2019-12-31 | $0.59 B | 31.43% |
| 2018-12-31 | $0.45 B | 69.37% |
| 2017-12-31 | $0.26 B | 39.49% |
| 2016-12-31 | $0.19 B | 117.89% |
| 2015-12-31 | $88 M | 116.24% |
| 2014-12-31 | $40.69 M | 21.62% |
| 2013-12-31 | $33.46 M | -41.87% |
| 2012-12-31 | $57.57 M | 509.66% |
| 2011-12-31 | $9.44 M | -121.31% |
| 2010-12-31 | $-44.32 M | 619.95% |
| 2009-12-31 | $-6.16 M | -8.76% |
| 2008-12-31 | $-6.75 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 7,363.14% | 🇺🇸 USA |
 Abbott Laboratories ABT | $38.82 B | 4,113.38% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | 1,078.89% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | 1,695.74% | 🇺🇸 USA |
 United Therapeutics UTHR | $5.98 B | 549.45% | 🇺🇸 USA |